SciBase Holding AB (OSTO:SCIB) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 ...

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today its engagement in a collaboration with the SKIN Research ...

The Skin and Cancer Reconstructive Surgery Center (SCARS Center) in California, US, has selected SciBase Holding’s Nevisense system for the detection of skin cancer early. This collaboration ...

Documentation etc. The board of directors' proposals and related documents will be available at the Company's office and on the Company's website, www.scibase.se, no later than two weeks prior to the ...

SciBase continues to expand geographically in the US with new practices added in Maryland, Colorado and as recently published Pennsylvania. The Fall Clinical conference will provide an opportunity ...

STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology disorders is pleased to announce the completion of a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announces today the collaboration ...

STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will attend a leading US ...